ResMed. has been granted a patent for a system that monitors user fatigue and sleep disordered breathing. The system utilizes non-obtrusive sensors to gather sleep data, detect snoring events, and generate assessments of the user’s fatigue and breathing patterns based on the collected information. GlobalData’s report on ResMed gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights ResMed Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on ResMed, was a key innovation area identified from patents. ResMed's grant share as of July 2024 was 54%. Grant share is based on the ratio of number of grants to total number of patents.

Fatigue monitoring system using sleep and breathing data

Source: United States Patent and Trademark Office (USPTO). Credit: ResMed Inc

The patent US12070325B2 describes a sophisticated system designed to monitor sleep disordered breathing in users. This system integrates sensing apparatus that generates both movement and audio signals to gather comprehensive sleep information. The processors within the system are tasked with detecting snoring events from the audio signal and obtaining sensor data related to respiratory movement and sleep measures. A key feature of the system is its ability to generate sleep disordered breathing measures based on detected snoring events while also rejecting non-user snoring sounds by correlating audio signals with sensor data. This ensures that the system accurately identifies and analyzes the user's sleep patterns.

Additionally, the patent outlines various methods and configurations to enhance the accuracy of snoring detection. For instance, it specifies that snoring measures are only considered when the user is present and asleep, and it can exclude non-snoring sounds. The system can also apply voice recognition features to suppress false snoring detections and correlate snoring patterns with apnea and hypopnea events. Furthermore, it is designed to operate effectively in environments with multiple sleeping individuals by determining correlations between audio and movement signals to isolate the user's snoring. Overall, this patent presents a comprehensive approach to monitoring and analyzing sleep disordered breathing, leveraging advanced signal processing techniques to improve accuracy and reliability.

To know more about GlobalData’s detailed insights on ResMed, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.